Le LÚzard
Classified in: Health, Covid-19 virus
Subjects: PSF, CFG

Government of Canada introduces new measures to address COVID-19 Omicron variant of concern


OTTAWA, ON, Nov. 26, 2021 /CNW/ - Public health authorities in South Africa have confirmed that a new COVID-19 variant of concern (B.1.1.529) has been detected in that country. Over the past 24 hours, this variant ? named Omicron by the World Health Organization ? has also been detected in other countries. At this time, the variant has not been detected in Canada.

Since the beginning of the pandemic, the Government of Canada has put measures in place at our border to reduce the risk of the importation and transmission of COVID-19 and its variants in Canada related to international travel.áToday, the Minister of Transport, the Honourable Omar Alghabra and the Minister of Health, the Honourable Jean-Yves Duclos, announced new border measures to protect the health and safety of Canadians.

As a precautionary measure, until January 31, 2022, the Government of Canada is implementing enhanced border measures for all travellers who have been in the Southern Africa region ? including South Africa, Eswatini, Lesotho, Botswana, Zimbabwe, Mozambique, and Namibia? within the last 14 days before arriving in Canada.

Foreign nationals who have travelled in any of these countries within the previous 14 days will not be permitted entry into Canada.

Canadian citizens, permanent residents and people with status under the Indian Act, regardless of their vaccination status or having had a previous history of testing positive for COVID-19, who have been in these countries in the previous 14 days will be subject to enhanced testing, screening, and quarantine measures.

These individuals will be required to obtain, within 72 hours of departure, a valid negative COVID-19 molecular test in a third country before continuing their journey to Canada. Upon arrival to Canada, regardless of their vaccination status or having had a previous history of testing positive for COVID-19, they will subject to immediate arrival testing. All travellers will also be required to complete a test on day 8 after arrival and quarantine for 14 days

All travellers will be referred to Public Health Agency of Canada (PHAC) officials to ensure they have a suitable quarantine plan. Those arriving by air will be required to stay in a designated quarantine facility while they await their arrival test result. They will not be permitted onward travel until their quarantine plan has been approved and they have received a negative arrival test result.

Those arriving by land may be allowed to proceed directly to their suitable isolation location. If they do not have a suitable plan ? where they will not have contact with anyone they haven't travelled with ? or do not have private transportation to their place of quarantine, they will be directed to stay at a designated quarantine facilityá

There will be increased scrutiny of quarantine plans for travellers from these countries and rigorous monitoring to ensure travellers are complying with quarantine measures. Further, travellers, regardless of their vaccination status or having had a previous history of testing positive for COVID-19, who have entered Canada from these countries in the past 14 days will be contacted and directed to be tested and to quarantine while they wait for the results of those tests. There are no exemptions specifically provided for in these new requirements.

The Government of Canada advises Canadians to avoid travelling to countries in this region and will continue to monitor the situation to inform current or future actions.

Canada continues to maintain pre-entry molecular testing for vaccinated and unvaccinated international travellers arriving from any country to reduce the risk of importation of COVID-19 including variants. PHAC has also been monitoring case data, through mandatory randomized testing upon entry into Canada.

The Government of Canada will continue to assess the evolving situation and adjust border measures as required. While the impact of all variants continues to be monitored in Canada, vaccination, in combination with public health and individual measures, is working to reduce the spread of COVID-19 and its variants.

Quotes

"Our government continues to take unprecedented and decisive action to protect the health and safety of Canadians. Today's measures, including new requirements for third-country pre-departure testing for travellers coming to Canada from certain southern African countries, are being put in place to prevent new variants of the COVID-19 virus from being introduced and spread in Canada."
The Honourable Omar Alghabra
Minister of Transport

"Canada's stringent testing and quarantine measures are in place to reduce the risk of importation and spread of COVID-19 and variants. These have proven effective in identifying imported cases of COVID-19 and preventing community spread. These new measures are being put in place out of an abundance of caution. We will continue to do what is necessary to protect the health of Canadians."
The Honourable Jean-Yves Duclos
Minister of Health

Quick Facts

Associated Link

SOURCE Health Canada


These press releases may also interest you

at 00:23
Based on its recent analysis of the global artificial intelligence (AI)-enabled drug discovery industry, Frost & Sullivan recognizes Insilico Medicine...

24 jan 2022
The kidney stones market potential growth difference will be USD 416.09 million from 2021 to 2026, as per the latest market analysis report by Technavio. The market is likely to witness an accelerating momentum at a CAGR of 6.69% during this period....

24 jan 2022
This week, the Foundation for Government Accountability (FGA) released data showing how Medicaid program mismanagement, federal restrictions, and Medicaid expansion have led to significant increases in improper payment rates. With a record-high 89...

24 jan 2022
Yosi Health, a provider of digital patient scheduling, registration, payment, and communication cloud-based software solutions, announced today they have added Hants Williams, PhD, RN, a professor at the State University of New York (SUNY) at Stony...

24 jan 2022
RemeGen Co., Ltd. (9995.HK), a commercial-ready biotechnology company, recently announced positive results from the completion of its Phase II trial in China for Telitacicept in the treatment of primary Sj÷gren's syndromeá("pSS"). A total of 42...

24 jan 2022
Demonstrating innovation leadership on a global level, ImmVira announced that, its custom-designed new-generation oncolytic herpes simplex virus ("oHSV") vector enabling CAR-T treatment for solid tumors has started pilot-scale manufacturing and...



News published on 26 november 2021 at 21:16 and distributed by: